IE
IE · IE · IE-PA-EU/1/22/1647/001
CAMCEVI 42 mg prolonged-release suspension for injection
ATC L02AE02
Last synced from HPRA (Ireland) on
Identification
ManufacturerAccord Healthcare S.L.U.
CountryIE (IE)
ATC codeL02AE02
Dispensing—
ReimbursedNo
SourceHPRA (Ireland)
Last synced6/8/2026
Packs · 1
- ie_pa_numberEU/1/22/1647/001
Annotations
No annotations yet.
Raw payload (JSON)
{
"form": "Prolonged-release suspension for injection",
"routes": [
"Subcutaneous use"
],
"source": "hpra",
"atc_all": [
"L02AE02"
],
"strength": null,
"pa_number": "EU/1/22/1647/001",
"substances": [
"Leuprorelin Mesilate",
"Leuprorelin"
],
"legal_basis": "Hybrid application (Article 10(3) of Directive No 2001/83/EC)",
"market_info": "Unknown",
"authorised_at": "24/06/2022",
"dispensing_status": "Product subject to prescription which may not be renewed (A)",
"registration_status": "AU",
"supply_legal_status": "Supply through pharmacies only",
"interchangeable_code": null
}Related drugs
Other records sharing ATC code L02AE02.
Access this data programmatically
Query CAMCEVI 42 mg prolonged-release suspension for injection and 610,000+ other drug records through a single REST API — with a last_synced_at provenance stamp on every response. Free tier includes 100 requests/day.